Stocks · Health care · Services-Medical Laboratories

Celcuity Inc.

CELC Clue Score19
United States Fiscal year ends December CIK 0001603454 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Baker Bros. Advisors LP
8 Sep 2025
10% owner
Buy indirect
4,212
$58.02
$244.40K
Baker Bros. Advisors LP
8 Sep 2025
10% owner
Buy indirect
388
$58.02
$22.51K
Baker Bros. Advisors LP
8 Sep 2025
10% owner
Buy indirect
151,524
$56.22
$8.52M
Baker Bros. Advisors LP
8 Sep 2025
10% owner
Buy indirect
13,976
$56.22
$785.73K
Leo Furcht
22 May 2023
Director
Buy
10,000
$10.32
$103.19K
Brian F. Sullivan
9 Dec 2022
Chief Executive Officer
Buy
260,869
$5.75
$1.50M
Polly A. Murphy
22 Nov 2022
Director
Buy
5,000
$9.68
$48.38K
Richard Nigon
9 Sep 2022
Director
Buy
5,000
$8.99
$44.94K
Richard Nigon
25 May 2022
Director
Buy
754
$5.94
$4.48K
Richard Nigon
11 Sep 2018
Director
Buy
9,747
$22.31
$217.46K
Richard Nigon
31 May 2018
Director
Buy
10,000
$19.04
$190.40K
Richard Nigon
28 Nov 2017
Director
Buy
7,500
$17.48
$131.10K
Richard Nigon
21 Nov 2017
Director
Buy
1,000
$18.15
$18.15K
Richard Nigon
20 Nov 2017
Director
Buy
7,500
$17.20
$129.00K

What was left out

Form 4 filings counted 173
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 12
Sales at will 25
Transactions with no price 0
Shares from compensation/vesting 6,234,857
Sales filed before the plan box existed 13
History held since 16 Oct 2017